{"nctId":"NCT00489827","briefTitle":"Glutamate for Metabolic Intervention in Coronary Surgery","startDateStruct":{"date":"2005-10"},"conditions":["Coronary Artery Bypass","Myocardial Ischemia","Myocardial Infarction","Coronary Artery Disease"],"count":865,"armGroups":[{"label":"Intravenous glutamate","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Intravenous glutamate infusion"]},{"label":"Saline infusion","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Intravenous infusion of saline"]}],"interventions":[{"name":"Intravenous infusion of saline","otherNames":[]},{"name":"Intravenous glutamate infusion","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* surgery for unstable coronary artery disease (unstable angina, non-STEMI)\n* accepted for surgery \\< 2 weeks after STEMI\n* coronary surgery for indications above performed with or without cardiopulmonary bypass\n* coronary surgery for indications above with or without simultaneous valve procedure\n\nExclusion Criteria:\n\n* informed consent not possible because of critical condition or other reason\n* preoperative use of inotropes or mechanical circulatory assist\n* preoperative dialysis\n* redo-procedure\n* unexpected intraoperative finding / event that increased the dignity of the procedure to overshadow the originally planned operation\n* body weight \\> 125 kg\n* food allergy known to have caused flush, rash or asthma","healthyVolunteers":false,"sex":"ALL","maximumAge":"85 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Perioperative Myocardial Infarction, Postoperative Heart Failure or Postoperative Mortality","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Perioperative Myocardial Injury","description":"p-CK-MB postoperative day 1, p-troponin-T postoperative day 3","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.27","spread":null},{"groupId":"OG001","value":"0.24","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Hemodynamic State","description":"Mixed venous oxygen saturation (SvO2) measured at weaning from cardiopulmonary bypass and on arrival to ICU","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.0","spread":"7.6"},{"groupId":"OG001","value":"72.2","spread":"7.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65.0","spread":"7.0"},{"groupId":"OG001","value":"64.9","spread":"6.9"}]}]}]},{"type":"SECONDARY","title":"Postoperative Hemodynamic State in Patients With Severely Reduced Left Ventricular Ejection Fraction (LVEF<0.40)","description":"Hemodynamic instability despite inotropes or need for IABP at the end of surgery in patients with severely reduced left ventricular ejection fraction (LVEF\\<0.40)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Renal Function","description":"maximum p-creatinine value recorded postoperatively \\< 30 days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"106","spread":"50"},{"groupId":"OG001","value":"106","spread":"50"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Postoperative Stroke < 24 Hours","description":"Incidence of Postoperative stroke \\< 24 hours of surgery verifed by CT-scan","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"ICU Stay","description":"ICU duration of stay (hours)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]}]},{"type":"SECONDARY","title":"Atrial Fibrillation","description":"Number of patients with atrial fibrillation recorded postoperatively","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"147","spread":null},{"groupId":"OG001","value":"152","spread":null}]}]}]},{"type":"SECONDARY","title":"Severe Circulatory Failure in CCS Class IV Patients","description":"Severe circulatory failure according to prespecified criteria as judged by a blinded endpoints committee in CCS class IV patients","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"10-year Survival","description":"10-year survival - related to intervention. Last follow-up August 3, 2022. Follow-up time ranged from 12.7-16.8 years.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"301","spread":null},{"groupId":"OG001","value":"301","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Mortality","description":"Postoperative mortality within 30 days of surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":54,"n":428},"commonTop":["Postoperative atrial fibrillation","Postoperative nausea","Respiratory","Infection","Skin reaction"]}}}